![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Eder, T.; Hess, A. K.; Konschak, R.; Stromberger, C.; Joehrens, K.; Fleischer, V; Hummel, M.; Balermpas, P.; Grün, J. von der; Linge, A.; Lohaus, F.; Krause, M.; Baumann, M.; Stuschke, M.; Zips, D.; Grosu, A. L.; Abdollahi, A.; Debus, J.; Belka, C.; Pigorsch, S.; Combs, E.; Budach, V und Tinhofer, I
(2019):
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
In: European Journal of Cancer, Bd. 116: S. 67-76
Tinhofer, I.; Budach, V.; Saki, M.; Konschak, R.; Niehr, F.; Jöhrens, K.; Weichert, W.; Linge, A.; Lohaus, F.; Krause, M.; Neumann, K.; Endris, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Avlar, M.; Grosu, A. L.; Abdollahi, A.; Debus, J.; Belka, C.; Pigorsch, S.; Combs, S. E.; Mönnich, D.; Zips, D. und Baumann, M.
(2016):
Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
In: European Journal of Cancer, Bd. 57: S. 78-86
Hecht, M.; Hahn, D.; Beutner, D.; Reichert, D.; Göhler, T.; Wurm, R.; Welslau, M.; Renziehausen, L.; Balermpas, P.; Bergmann, T.; Assmann, M.; Belka, C.; Orlowski, K.; Finzsch, M.; Illerhaus, G. und Fietkau, R.
(2016):
Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial).
In: Annals of Oncology, Bd. 27
Hecht, M.; Hahn, D.; Beutner, D.; Reichert, D.; Göhler, T.; Wurm, R.; Welslau, M.; Renziehausen, L.; Balermpas, P.; Bergmann, T.; Aßmann, M.; Belka, C.; Orlowski, K.; Finzsch, M.; Illerhaus, G. und Fietkau, R.
(2016):
Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial).
In: Oncology Research and Treatment, Bd. 39: S. 171
Linge, A.; Lohaus, F.; Löck, S.; Gudziol, V.; Nowak, A.; Neubeck, C.; von Tinhofer, I.; Budach, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Avlar, M.; Grosu, A.-L.; Abdollahi, A.; Debus, J.; Bayer, C.; Belka, C.; Pigorsch, S.; Combs, S. E.; Mönnich, D.; Zips, D.; Baretton, G. B.; Buchholz, F.; Baumann, M. und Krause, M.
(2016):
Impact of tumour hypoxia and cancer stem cells on loco-regional control after primary radiochemotherapy in locally advanced HNSCC - results of a multicentre biomarker study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
In: Oncology Research and Treatment, Bd. 39: S. 22-23